Talaris Therapeutics, Inc. Contracts & Agreements
43 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (14)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (15)
- Confirmatory offer letter, by and between the Registrant and Ryan Robinson, dated June 25, 2024 (Filed With SEC on August 8, 2024)
- Amended Non-Employee Director Compensation Policy (Filed With SEC on May 13, 2024)
- Description of Securities (Filed With SEC on March 19, 2024)
- Underwriting Agreement, dated January 25, 2024, by and among the Company, Jefferies LLC, Piper Sandler & Co., Guggenheim Securities, LLC and Truist Securities, Inc (Filed With SEC on January 26, 2024)
- Side Letter, dated as of November 10, 2023, by and between the Registrant and Ryan Robinson (Filed With SEC on November 14, 2023)
- Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Sandeep Kulkarni, M.D (Filed With SEC on October 20, 2023)
- Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Brad Middlekauff, M.D (Filed With SEC on October 20, 2023)
- Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Susan Dana Jones, Ph.D (Filed With SEC on October 20, 2023)
- Offer Letter, dated as of June 7, 2023, by and between Tourmaline Bio, Inc. and Ryan Robinson (Filed With SEC on October 20, 2023)
- Tourmaline Bio, Inc. 2023 Equity Incentive Plan (Filed With SEC on October 20, 2023)
- Forms of Option Grant Notice, Option Agreement and Notice of Exercise under Tourmaline Bio, Inc. 2023 Equity Incentive Plan (Filed With SEC on October 20, 2023)
- Forms of Restricted Stock Unit Grant Notice and Award Agreement under Tourmaline Bio, Inc. 2023 Equity Incentive Plan (Filed With SEC on October 20, 2023)
- Tourmaline Bio, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on October 20, 2023)
- 2022 Equity Incentive Plan of Tourmaline Bio, Inc., and form of award agreements thereunder (Filed With SEC on July 20, 2023)
- License Agreement by and between Tourmaline Bio, LLC and Pfizer Inc., dated May 3, 2022 (Filed With SEC on July 20, 2023)
- License Agreement by and between Tourmaline Bio, LLC and Lonza Sales AG, dated May 16, 2022 (Filed With SEC on July 20, 2023)
- Strategic Advisor Agreement, by and between the Registrant and Scott Requadt, dated May 26, 2023 (Filed With SEC on July 20, 2023)
- Form of Indemnification Agreement between Tourmaline Bio, Inc. and each of its directors and executive officers (Filed With SEC on July 20, 2023)
- Agreement and Plan of Merger, dated as of June 22, 2023, by and among Talaris Therapeutics, Inc., Terrain Merger Sub, Inc. and Tourmaline Bio, Inc (Filed With SEC on June 22, 2023)
- Form of Tourmaline Support Agreement (Filed With SEC on June 22, 2023)
- Forms of Talaris Support Agreements (Filed With SEC on June 22, 2023)
- Form of Lock-Up Agreement (Filed With SEC on June 22, 2023)
- Lease Agreement between the Registrant and the University of Louisville, dated as of November 1, 2018, as amended on (Filed With SEC on May 15, 2023)
- Transition Agreement, by and between the Registrant and Suzanne T. Ildstad, dated August 13, 2022 (Filed With SEC on November 10, 2022)
- Description of Securities (Filed With SEC on March 17, 2022)
- Form of Underwriting Agreement (Filed With SEC on May 3, 2021)
- 2021 Stock Option and Incentive Plan and form of award agreements thereunder (Filed With SEC on May 3, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on May 3, 2021)
- Forms of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on May 3, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on May 3, 2021)
- Specimen Common Stock Certificate (Filed With SEC on April 16, 2021)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of September 22, 2020 (Filed With SEC on April 16, 2021)
- Second Amended and Restated 2018 Equity Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on April 16, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on April 16, 2021)
- Severance and Change in Control Plan (Filed With SEC on April 16, 2021)
- Lease Agreement between the Registrant and the University of Louisville, dated as of November 1, 2018, as amended on July 1, 2019, February 1, 2020, and May 15, 2020 (Filed With SEC on April 16, 2021)
- Employment Agreement, by and between the Registrant and Scott Requadt, dated November 1, 2018 (Filed With SEC on April 16, 2021)
- Employment Agreement, by and between the Registrant and Suzanne T. Ildstad, dated November 1, 2018 (Filed With SEC on April 16, 2021)
- Offer Letter, by and between the Registrant and Nancy Krieger, dated November 1, 2018 (Filed With SEC on April 16, 2021)
- Offer Letter, by and between the Registrant and Michael Zdanowski, dated September 29, 2020 (Filed With SEC on April 16, 2021)
- Offer Letter, by and between the Registrant and Mary Kay Fenton, as amended, dated January 21, 2021 (Filed With SEC on April 16, 2021)
- Amended and Restated Exclusive License Agreement, by and between the Registrant and University of Louisville Research Foundation, Inc., dated October 31, 2018 (Filed With SEC on April 16, 2021)
- Deferred Compensation Plan for Non-Employee Directors of the Registrant (Filed With SEC on April 16, 2021)
